Catalog Number 1012451-08 |
Device Problems
Difficult to Remove (1528); Improper or Incorrect Procedure or Method (2017)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 11/24/2016 |
Event Type
malfunction
|
Manufacturer Narrative
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Device: incorrect prep; failure to submerge balloon to activate coating.The customer reported the device was discarded.Investigation is not yet complete.A follow up report will be submitted with all relevant information.The other 3 nc trek devices referenced are filed under separate medwatch reports.
|
|
Event Description
|
It was reported that prior to use, during device preparation, the protective sheath of the nc trek balloon met resistance during removal.Additionally, the device was not submerged in sterile heparinized normal saline to activate the coating; however, the device was successfully used in the patient without reported issue.This occurred with 4 separate devices.There was no reported adverse patient effect.There was no reported clinically significant delay in the procedure.No additional information was provided.
|
|
Manufacturer Narrative
|
(b)(4).The device was not returned for analysis.The complaint investigation determined the reported difficulty was related to manufacturing issues associated with the protective sheath.On (b)(6) 2017, abbott vascular decided to initiate a voluntary field action for some sizes and lots of the nc trek family of dilatation catheters for difficulty to remove sheath which may lead to inflation or deflation issues.Abbott vascular performed a comprehensive investigation which included device analysis, manufacturing evaluation and trend analysis.The root cause identification was complicated by the fact that users were describing multiple symptoms when reporting the complaints.To date, the frequency of worldwide reported events for difficulties removing the protective balloon sheath, inflation and deflation has reached an actionable limit, thus abbott vascular communicated the voluntary field action to the fda on (b)(6) 2017 [medwatch # 2024168-2017-02310].Corrective action has been implemented per site operating procedures.The product will continue to be trended.The abbott internal recall number is 2024168-3/14/2017-002-r.
|
|
Search Alerts/Recalls
|